A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

November 13, 2025

Study Completion Date

November 13, 2025

Conditions

Alzheimer Disease

Interventions

DRUG

Aricept Tablet

Donepezil Tablet once daily P.O

DRUG

IVL3003

Donepezil Long-Acting Injection, once S.C Injection

DRUG

IVL3003

Donepezil Long-Acting Injection, once IM Injection

Trial Locations (1)

Nucleus Network, Melbourne